PF-Atlas › Clinical Trials › NCT00311883
Hydroxychloroquine in Cystic Fibrosis
hydroxychloroquine · Phase 1
Registry ID
NCT00311883
Phase
Phase 1
Status
Completed
Drug / intervention
hydroxychloroquine
Sponsor
Vanderbilt University
Start
2006-03
Enrollment
20
Locations
1
About this trial
Study levels of inflammatory mediators in induced sputum of patients with cystic fibrosis before and after a 4 week course of oral hydroxychloroquine.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00311883 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.